INS and metabolic syndrome: Insulin resistant states such as obesity, metabolic syndrome, and DM2 cause impairment of downstream GLUT4 translocation by disruption of insulin receptor substrate-1 (IRS-1) associated PI3K signaling in the metabolic pathway of insulin [26].